SCHEMBL3677883

SCHEMBL3677883

CC(C)(C)CNC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27788709 0.97 BCHE (0.33)
SCHEMBL2824552 0.77 BCHE (0.36)
SCHEMBL11196421 0.74
SCHEMBL1934610 0.74
SCHEMBL2335314 0.74
SCHEMBL73996 0.74
SCHEMBL4866354 0.74 ALDH1A1 (0.48)
SCHEMBL8962237 0.72 POLB (0.38)
SCHEMBL2891950 0.72
SCHEMBL31137802 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393493-A1 COMPOUNDS GlaxoSmithKline LLC (US) 2011-12-14 EP disclosed
US-20100196321-A1 COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-05 US disclosed
WO-2010088394-A1 COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-05 WO disclosed
US-20080312281-A1 G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and Diabetes PROSIDION LIMITED (GB) 2008-12-18 US disclosed
EP-1838311-A1 G-PROTEIN COUPLED RECEPTOR (GPR116) AGONISTS AND USE THEREOF FOR TREATING OBESITY AND DIABETES Prosidion Limited (GB) 2007-10-03 EP disclosed
WO-2006067531-A1 G-PROTEIN COUPLED RECEPTOR (GPR116) AGONISTS AND USE THEREOF FOR TREATING OBESITY AND DIABETES PROSIDION LTD (GB) 2006-06-29 WO disclosed
US-4388246-A THERMAL SPLITTING OF CARBAMATES BAYER AKTIENGESELLSCHAFT (DE) 1983-06-14 US disclosed